Scleroderma and the taxanes. Is there really a link?
- 1 July 2004
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 29 (4) , 360-362
Abstract
Scleroderma has been associated with exposure to many substances in the past ranging from vinyl chloride to silicon dioxide. In recent years there have been a number of case reports linking modern chemotherapy agents, such as the taxanes to the development of scleroderma like changes. We present a further case of scleroderma in association with chemotherapy but question the role of some of the agents previously implicated. A brief review of the current literature is included.Keywords
This publication has 5 references indexed in Scilit:
- Scleroderma-like cutaneous lesions induced by paclitaxel: A case studyJournal of the American Academy of Dermatology, 2003
- Scleroderma-like drug reaction to paclitaxel (TaxolR)British Journal of Dermatology, 2002
- Topotecan and the development of scleroderma or a scleroderma‐like illnessArthritis & Rheumatism, 2002
- Cutaneous fibrosis induced by docetaxelCancer, 2000
- Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three casesCancer, 1995